Consortium for Clinical Research and Innovation Singapore

About Consortium for Clinical Research and Innovation Singapore

The Consortium for Clinical Research and Innovation Singapore (CRIS) is a leading organisation dedicated to advancing clinical research and innovation in Singapore. Established with the vision of enhancing healthcare through research, CRIS collaborates with various stakeholders including academic institutions, healthcare providers, and industry partners.

At CRIS, we focus on fostering a robust ecosystem that supports clinical trials and research initiatives. Our core activities include facilitating clinical research, providing training and resources for researchers, and promoting best practices in clinical trial management.

We aim to bridge the gap between scientific discovery and patient care by translating research findings into practical applications. Our commitment to innovation drives us to explore new methodologies and technologies that can improve patient outcomes.

CRIS also plays a pivotal role in policy advocacy, working closely with government agencies to shape the regulatory landscape for clinical research in Singapore. We believe that a supportive regulatory environment is essential for fostering innovation and attracting global research initiatives.

Through our collaborative efforts, we strive to position Singapore as a global hub for clinical research and innovation. Our team of experts is dedicated to ensuring that our research initiatives are conducted ethically and with the highest standards of quality.

In summary, the Consortium for Clinical Research and Innovation Singapore is at the forefront of clinical research, committed to improving healthcare through innovation and collaboration.